Shanmei Liao
About Shanmei Liao
Shanmei Liao is the Senior Director at BeiGene, with extensive experience in biostatistics and a strong educational background.
Current Position at BeiGene
Shanmei Liao is currently serving as Senior Director at BeiGene, a global biotechnology company. Since joining in November 2017, Liao has leveraged her extensive experience in biostatistics to contribute significantly to BeiGene's research and development efforts. Her role involves leading teams, managing projects, and ensuring the accuracy and efficacy of biostatistical analyses.
Professional Experience at Pfizer
Shanmei Liao accumulated seven years of professional experience at Pfizer, where she held various roles from Senior Statistician to Associate Director. She began her journey at Pfizer in 2009 as a Senior Statistician. By 2010, she was promoted to Manager and later advanced to Senior Manager from 2012 to 2015. Her final role at Pfizer was as Associate Director in New York, which she held from 2015 to 2017. During her tenure, she gained in-depth knowledge of biostatistics, clinical trials, and data management.
Previous Roles in Biostatistics
Before her work at Pfizer, Shanmei Liao served as a Senior Biostatistician at Bristol-Myers Squibb from 2007 to 2009. Prior to that, she gained early experience in the field with a position as a Co-op at GSK in 2006. These roles helped her establish a solid foundation in biostatistics, contributing to her later successes in major pharmaceutical companies.
Educational Background
Shanmei Liao holds a Doctor of Philosophy (Ph.D.) from the University of California, Davis, where she studied from 2002 to 2006. She also earned a Bachelor's degree from Peking University, where she studied from 1998 to 2002. Her strong academic background laid the groundwork for her expertise in biostatistics and her subsequent career in the pharmaceutical industry.
International Experience
Shanmei Liao has a diverse international perspective, having worked in both the United States and China. Her global experience has enriched her approach to biostatistical projects, allowing her to understand and navigate various regulatory environments and work with international teams effectively. This background provides her with a unique edge in her current role at BeiGene.